$NVDA NEWS Nvidia stock tumbles as new Biden rule threatens new curbs on chip exports BSE - Delayed Quote • INR Ajanta Pharma Limited (AJANTPHARM.BO) Follow Compare 2,783.75 -51.90 (-1.83%) At close: 3:40:30 PM GMT+5:30 All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Ajanta Pharma Ltd (BOM:532331) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid ... Ajanta Pharma Ltd (BOM:532331) reports a robust 15% revenue increase, driven by Branded Generics, despite hurdles in the US market. Performance Overview Trailing total returns as of 1/13/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX Return AJANTPHARM.BO S&P BSE SENSEX YTD -5.86% -2.45% 1-Year +29.20% +5.18% 3-Year +87.37% +24.82%